MarketCap
Facebook
X
TelegramQuarterly report 2024-Q3
added 11-12-2024
Psychemedics Corporation ROCE Ratio 2011-2026 | PMD
Annual ROCE Ratio Psychemedics Corporation
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -43.78 | -10.05 | 1.71 | -48.48 | 13.82 | 36.39 | 36.61 | 49.23 | 7.83 | 22.9 | 41.99 | 41.0 | 50.36 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 50.36 | -48.48 | 15.35 |
Quarterly ROCE Ratio Psychemedics Corporation
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -50.51 | -54.49 | -43.4 | -24.66 | -27.86 | -16.16 | -14.46 | -6.14 | -0.08 | 9.17 | 13.62 | 8.55 | -0.31 | -17.63 | -45.63 | -48.48 | -43.22 | -24.03 | 10.28 | 17.82 | 29.58 | 32.95 | 36.04 | 40.59 | 42.9 | 43.58 | 41.79 | 43.81 | 56.65 | 70.96 | 76.97 | 64.78 | 42.45 | 20.87 | 8.72 | 12.6 | 19.09 | 24.07 | 31.3 | 36.54 | 37.49 | 41.96 | 45.79 | 46.48 | 42.2 | 40.78 | 41.5 | 43.98 | 46.61 | 50.24 | 51.35 | 52.58 | 16.38 | 15.93 | 13.5 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 76.97 | -54.49 | 18.28 |
ROCE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-89.9 | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
58.25 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Bioventus
BVS
|
29.32 | $ 8.9 | 0.39 % | $ 593 M |  USA |
 |
Brainsway Ltd.
BWAY
|
-17.75 | $ 13.85 | 1.47 % | $ 99.4 M |  Israel |
 |
Castle Biosciences
CSTL
|
1.9 | $ 26.04 | 0.81 % | $ 723 M | USA |
 |
Aspira Women's Health
AWH
|
-486.78 | - | -6.19 % | $ 10.5 M | USA |
 |
DexCom
DXCM
|
33.2 | $ 68.33 | 2.99 % | $ 26.7 B | USA |
 |
Guardant Health
GH
|
440.3 | $ 87.63 | 0.52 % | $ 11 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-2.26 | - | - | $ 562 M |  Britain |
 |
Charles River Laboratories International
CRL
|
0.8 | $ 154.73 | 1.82 % | $ 7.67 B | USA |
 |
CareDx, Inc
CDNA
|
-10.16 | $ 17.59 | 1.56 % | $ 937 M | USA |
 |
Accelerate Diagnostics
AXDX
|
62.7 | - | -61.36 % | $ 2.46 M | USA |
 |
IQVIA Holdings
IQV
|
33.55 | $ 168.86 | 2.41 % | $ 29 B | USA |
 |
Exact Sciences Corporation
EXAS
|
-8.59 | $ 103.89 | 0.04 % | $ 19.6 B | USA |
 |
Global Cord Blood Corporation
CO
|
12.48 | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
-18.87 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-347.69 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-15.41 | - | 0.12 % | $ 80.1 M | China |
 |
Fulgent Genetics
FLGT
|
-6.52 | $ 15.62 | 4.45 % | $ 472 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
9.75 | - | - | $ 10.7 B | USA |
|
Biodesix
BDSX
|
-41.6 | $ 16.88 | -2.37 % | $ 2.19 B | USA |
 |
ICON Public Limited Company
ICLR
|
4.69 | $ 100.35 | 2.81 % | $ 8.28 B |  Irlanda |
 |
Anixa Biosciences
ANIX
|
-77.18 | $ 2.9 | 2.11 % | $ 94.1 K | USA |
 |
Danaher Corporation
DHR
|
8.93 | $ 195.77 | 2.29 % | $ 140 B | USA |
 |
NeoGenomics
NEO
|
-9.11 | $ 8.36 | 1.46 % | $ 1.07 B | USA |
 |
Biocept
BIOC
|
-360.98 | - | -13.05 % | $ 7.29 M | USA |
 |
Heska Corporation
HSKA
|
-4.81 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-219.45 | - | -20.0 % | $ 1.06 M | USA |
 |
Pacific Biosciences of California
PACB
|
-10354.48 | $ 1.4 | 2.95 % | $ 420 M | USA |
 |
Illumina
ILMN
|
-35.1 | $ 121.89 | 2.18 % | $ 19.4 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
21.7 | $ 198.82 | -0.06 % | $ 22.1 B | USA |
 |
QIAGEN N.V.
QGEN
|
1.9 | - | - | $ 10.6 B |  Niderland |
 |
Agilent Technologies
A
|
25.0 | $ 113.9 | 1.85 % | $ 34.6 B | USA |
 |
BioNano Genomics
BNGO
|
-293.94 | $ 1.12 | 0.9 % | $ 1.42 M | USA |
 |
DarioHealth Corp.
DRIO
|
-66.97 | $ 9.28 | 10.24 % | $ 263 M | Israel |
 |
Neogen Corporation
NEOG
|
-51.22 | $ 9.32 | 2.25 % | $ 2.02 B | USA |
 |
Lantheus Holdings
LNTH
|
28.52 | $ 78.96 | 0.59 % | $ 5.33 B | USA |
 |
Chembio Diagnostics
CEMI
|
-132.81 | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
1809.55 | - | - | $ 9.42 M | Israel |
 |
Co-Diagnostics
CODX
|
-47.68 | $ 4.4 | 101.83 % | $ 129 M | USA |
 |
Medpace Holdings
MEDP
|
116.53 | $ 452.34 | -0.29 % | $ 13 B | USA |
 |
Motus GI Holdings
MOTS
|
-443.13 | - | -34.28 % | $ 263 K | Israel |
 |
Mettler-Toledo International
MTD
|
35.8 | $ 1 219.76 | 1.76 % | $ 25.1 B |  Schweiz |
 |
Celcuity
CELC
|
-97.97 | $ 114.23 | -0.58 % | $ 4.51 B | USA |
 |
DermTech
DMTK
|
-181.44 | - | -11.32 % | $ 2.94 M | USA |
 |
Twist Bioscience Corporation
TWST
|
-28.81 | $ 46.61 | 3.55 % | $ 2.79 B | USA |
 |
National Research Corporation
NRC
|
161.47 | $ 18.05 | 3.71 % | $ 404 M | USA |
 |
Invitae Corporation
NVTA
|
-93.18 | - | - | $ 21.2 M | USA |
 |
Enzo Biochem
ENZ
|
-22.04 | - | -8.98 % | $ 14.8 K | USA |
 |
Natera
NTRA
|
-76.66 | $ 199.84 | 1.09 % | $ 19.7 B | USA |